USAIC has created an ecosystem committed to driving a global dialogue on BioPharma & Healthcare innovation, attracting a diverse mix of senior industry professionals and catalyzing partnerships, new ideas, networks and regulatory reform. This unique platform creates mutually beneficial opportunities and relationships for the global Life Sciences & Healthcare industry.
As a service to the BioPharma community in these unprecedented times, USAIC is offering Free Registration for its annual summit.
Registration is closed. Thanks for your overwhelming response.
The Summit has reached full capacity. Registration is closed. There is no onsite registration.
Thanks for your overwhelming response. See you at 2020 summit!
Chair and Master of Ceremonies (Emcee) - Dr. Andrew Plump, President of Research and Development, Takeda Pharmaceutical 17th annual BioPharma & Healthcare Summit
Virtual Summit
Date: Wednesday, May 3, 2023
Time: 8 AM EST to 4:30 PM EST (Eastern Standard Time)
Panelists: Badhri Srinivasan, Head, Global Clinical Operations, Novartis Dr. Cynthia Verst, President, Design & Delivery Innovation for R&D Solutions, IQVIA Dr. Naresh Trehan, Chairman, Medanta - the Medicity Dr. Shiv Kumar Sarin, Chancellor, Institute of Liver and Biliary Sciences Dr. Vinod Paul, Member, National Institution for Transforming India, the NITI Aayog
Moderator: Dr. Andrew Plump, President of Research and Development, Takeda Pharmaceutical
9:45 AM - 9:50 AM
Polling + Break
9:50 AM - 10:35 AM
Panel: BioPharma Industry & Investment Outlook
Panelists: Daphne Zohar, Founder & Chief Executive Officer, PureTech Health Christopher Viehbacher, President & CEO, Biogen Rajiv Kaul, Portfolio Manager, Fidelity Investments Dr. Stephen Knight, President & Managing Partner, F-Prime Capital Theresa Tse, Chairwoman of Board Committee, Sino Biopharmaceutical Limited
Moderator: Dr. Samuel Waksal, Chairman and Chief Executive Officer, Graviton Biosciences
10:35 AM - 10:40 AM
Polling + Break
10:40 AM - 11:20 AM
Fireside Chat Joaquin Duato, Chairman & CEO, Johnson & Johnson
Moderator: Kenneth Frazier, Chairman, Health Assurance Initiatives, General Catalyst and former Chairman & CEO, Merck & Co.
11:20 AM - 11:25 AM
Polling + Break
11:25 AM - 12:00 PM
Fireside Chat Dr. Robert Califf, Commissioner of Food and Drugs, US Food and Drug Administration
Moderator: Dr. William Chin, Professor of Medicine, Emeritus, Harvard Medical School
12:00 PM - 12:10 PM
Polling + Break
12:10 PM - 12:55 PM
Panel: Industry Academic Partnerships
Panelists: Dr. Elias Zerhouni, Vice Chairman & President, OPKO Health Dr. Marcus Schindler, Executive Vice President, Research & Early Development and Chief Scientific Officer, Novo Nordisk Dr. Mathai Mammen, CEO Designate, FogPharma Dr. Phillip Sharp, Institute Professor, Koch Institute, MIT Dr. Priya Singhal, Executive Vice President & Head of Development, Biogen
Panelists: Dr. Alise Reicin, Chief Executive Officer, Tectonic Therapeutic Dr. Frank Nestle, Global Head of Research and Chief Scientific Officer, Sanofi Dr. Kathy Seidl, Vice President, Head of the Oncology Drug Discovery Unit, Takeda Dr. Katy Rezvani, Professor of Medicine, Chief of Section for Cellular Therapy, Director of Translational Research, MD Anderson Cancer Center Rehan Verjee, Co-Founder & Chief Executive Officer, Stealth start-up
Moderator: Dr. James Bradner, Physician Scientist, Former President, Novartis Institutes for BioMedical Research
1:45 PM - 1:50 PM
Polling + Break
1:50 PM - 2:35 PM
Panel: Digital & Data Science
Panelists: Dr. Alice Zhang, Co-Founder & CEO, Verge Genomics Dr. Anne Heatherington, Head of Data Sciences Institute, Takeda Pharmaceuticals Dr. Dina Katabi, Professor of Computer Science, Member - CSAIL, Massachusetts Institute of Technology Dr. Junaid Bajwa, Chief Medical Scientist, Microsoft Sastry Chilukuri former Co-CEO, Medidata
Moderator: Dr. Najat Khan, Chief Data Science Officer and Global Head of Janssen R&D Strategy and Operations, Janssen R&D, Johnson & Johnson
2:35 PM - 2:40 PM
Polling + Break
2:40 PM - 3:20 PM
Fireside Chat Dr. Albert Bourla, Chairman and Chief Executive Officer, Pfizer
Panelists: Dr. Andrew Plump, President of Research and Development, Takeda Pharmaceutical Dr. Daniel Skovronsky, Executive Vice President, Chief Scientific and Medical Officer, Eli Lilly and Company Dr. David Reese, Executive Vice President, Research and Development, Amgen Dr. Fiona Marshall, President, Novartis Institutes for BioMedical Research
